Autoimmunity markers in subjects with diabetes
Journal Title: Journal of Pre-Clinical and Clinical Research - Year 2016, Vol 10, Issue 1
Abstract
[b]Introduction.[/b] Diabetes is a growing social and epidemiological problem. Accordingly, the incidence of complications associated with diabetes can cause a persistent high percentage of diseases of the cardiovascular system, kidney and nervous systems, and impaired vision. [b]Objective.[/b] The aim of the study was to evaluate the incidence of immunological markers in patients with type 1 diabetes and those with type 2 diabetes: the anti-GAD, ANA, AMA, ASMA, APCA and LKM, compared to healthy people. Another objective of the study was to evaluate the correlation between their presence and the degree of metabolic control in both groups. [b]Materials and methods[/b]. The study comprised 100 subjects aged 25–75 years with a body mass index (BMI) between 20–30 kg / m2, hospitalized in the Department of Internal Diseases, Diabetology and Endocrinology, at the Medical University of Warsaw, with previously diagnosed diabetes who were assigned to one of 2 groups (50 subjects with type 1 diabetes and 50 subjects with type 2 diabetes). The control group consisted of 21 healthy individuals without the diagnosis of diabetes and a prediabetic state. All the study participants had the examined antibodies determined along with the panel of biochemical tests and neurological examination for diabetic neuropathy and fundus examination. [b]Results. [/b]Anti-GAD antibodies were present in both groups of patients. Their presence was found in 30% of people with type 1 diabetes and in 16% of people with diabetes type 2. The presence of ANA antibodies was found in 24% of people with type 1 diabetes and 22% of people with type 2 diabetes. There was no correlation between the presence of ANA antibodies ANA and duration of diabetes. In the group of patients with type 1 diabetes, there was a correlation between the presence of ANA and the incidence of diabetic polyneuropathy. ASMA and APCA antibodies occurred with equal frequency in both studied groups (4% vs. 10%). There were no antibodies of AMA or anti-LKM in any of the patients. [b]Conclusions[/b]. Marking of ANA antibodies in patients with type 1 diabetes may be a marker used to isolate a group of patients at risk of developing diabetic neuropathy. The presence of anti-GAD in type 2 diabetes may be a LADA marker which specifically marks the group of patients with type 2 diabetes, in whom there is a faster metabolic death of beta cells. The current classification of diabetes is vague, and in the near future it should be modified based on specific patient characteristics, phenotypic appearance, as well as the results of additional tests. Determination of antibodies AMA, ASMA, APCA and anti-LKM does not seem to be significant in the diagnosis of diabetes and its chronic complications.
Authors and Affiliations
Joanna Litwińczuk-Hajduk, Małgorzata Bernat-Karpińska, Marek Kowrach, Paweł Piątkiewicz
Keywords
Related Articles
- EP ID EP79295
- DOI 10.5604/18982395.1208185
- Views 77
- Downloads 0
Analysis of procedures implemented by emergency medical teams in the event of cardiac arrest in the city of Lublin, Poland
[b]Aim. [/b]The aim of this study was to present an analysis of emergency teams’ actions in case of cardiac arrest. [b]Method[/b]. The studied material consisted of emergency teams’ card records with cases of cardiac a...
Application of high performance thin layer chromatography method for ophthalmological preparations containing anthocyanins fractions
The aim of the investigation was to elaborate a fast, easy, and cheap method of analysis of ophthalmological preparations containing anthocyanins fractions. A high performance thin layer chromatography (HPTLC) was applie...
Pulmonary embolism associated with oral contraceptive use – Case report
A 25-year-old female patient with a history of oral contraceptive use was admitted to hospital because of exertional dyspnoea, palpitations, chest discomfort and weakness. Since the clinical presentation was suggestive o...
Influence of irbesartan on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
The influence of irbesartan on the hypoglycemic effect of gliclazide was studied in normal/diabetic rats and normal rabbits. Gliclazide and irbesartan was studied at a dose of 1.44 mg/200 g, 5.4 mg/200 g in normal/diabe...
Differences in diazepam influence on the behaviour of rabbits under spontaneous conditions, and after electrical stimulation of the ventromedial hypothalamic nucleus
The purpose of the present study was to compare the influence of diazepam on different forms of rabbits’ behaviour under stress and spontaneodial hypothalamic nucleus, escape reactionus conditions. The experimental mode...